Jana Lemke, Nadine Mengers, Louis Schmidt, Lukas Schulig, Stefanie König, Pascal Rosendahl, Frieda-Marie Bartz, Ulrike Garscha, Patrick J. Bednarski and Andreas Link*,
{"title":"正向变构KV7.2/3通道调节剂在改善亲脂性和水溶性平衡方面的先导优化","authors":"Jana Lemke, Nadine Mengers, Louis Schmidt, Lukas Schulig, Stefanie König, Pascal Rosendahl, Frieda-Marie Bartz, Ulrike Garscha, Patrick J. Bednarski and Andreas Link*, ","doi":"10.1021/acs.jmedchem.4c0311210.1021/acs.jmedchem.4c03112","DOIUrl":null,"url":null,"abstract":"<p >The voltage-gated potassium channel K<sub>V</sub>7.2/3 is gaining attention for its association with several medical indications. While recently reported, potent compounds aimed to fill the therapeutic gap left by market-withdrawn activators, key physicochemical parameters did not meet the requirements of potential drug candidates. Targeting the membrane-located channel requires subtly balancing lipophilicity, activity, and aqueous solubility. This publication describes the lead optimization of a highly active compound toward optimized physicochemical parameters. Out of 42 newly synthesized compounds, 30 showed activity on K<sub>V</sub>7.2/3 channels, and 15 had also an increased solubility compared the to hit compound. The integration of a three-dimensional bulky structure and the probable onset of chameleonic behavior, led to a 20-fold solubility increase (<i>S</i> = 21.7 vs 1.1 μM) and only slightly reduced potency (pEC<sub>50</sub> = 7.42 vs 7.96) for the lead. Additionally, the target engagement of the compound was theoretically enhanced by a reduction of membrane retention.</p>","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"68 8","pages":"8377–8399 8377–8399"},"PeriodicalIF":6.8000,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lead Optimization of Positive Allosteric KV7.2/3 Channel Modulators toward Improved Balance of Lipophilicity and Aqueous Solubility\",\"authors\":\"Jana Lemke, Nadine Mengers, Louis Schmidt, Lukas Schulig, Stefanie König, Pascal Rosendahl, Frieda-Marie Bartz, Ulrike Garscha, Patrick J. Bednarski and Andreas Link*, \",\"doi\":\"10.1021/acs.jmedchem.4c0311210.1021/acs.jmedchem.4c03112\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >The voltage-gated potassium channel K<sub>V</sub>7.2/3 is gaining attention for its association with several medical indications. While recently reported, potent compounds aimed to fill the therapeutic gap left by market-withdrawn activators, key physicochemical parameters did not meet the requirements of potential drug candidates. Targeting the membrane-located channel requires subtly balancing lipophilicity, activity, and aqueous solubility. This publication describes the lead optimization of a highly active compound toward optimized physicochemical parameters. Out of 42 newly synthesized compounds, 30 showed activity on K<sub>V</sub>7.2/3 channels, and 15 had also an increased solubility compared the to hit compound. The integration of a three-dimensional bulky structure and the probable onset of chameleonic behavior, led to a 20-fold solubility increase (<i>S</i> = 21.7 vs 1.1 μM) and only slightly reduced potency (pEC<sub>50</sub> = 7.42 vs 7.96) for the lead. Additionally, the target engagement of the compound was theoretically enhanced by a reduction of membrane retention.</p>\",\"PeriodicalId\":46,\"journal\":{\"name\":\"Journal of Medicinal Chemistry\",\"volume\":\"68 8\",\"pages\":\"8377–8399 8377–8399\"},\"PeriodicalIF\":6.8000,\"publicationDate\":\"2025-04-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c03112\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c03112","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
摘要
电压门控钾通道KV7.2/3因其与几种医学适应症的关联而受到关注。虽然最近有报道称,有效的化合物旨在填补市场上退出的活化剂留下的治疗空白,但关键的物理化学参数不符合潜在候选药物的要求。靶向膜定位通道需要巧妙地平衡亲脂性、活性和水溶性。本出版物描述了一种高活性化合物对优化物理化学参数的先导优化。在42个新合成的化合物中,30个在KV7.2/3通道上表现出活性,15个化合物的溶解度也比被击中的化合物高。三维体积结构的整合和变色龙行为的可能发生,导致铅的溶解度增加了20倍(S = 21.7 vs 1.1 μM),而效价仅略有降低(pEC50 = 7.42 vs 7.96)。此外,从理论上讲,通过减少膜潴留,化合物的靶接触得到了增强。
Lead Optimization of Positive Allosteric KV7.2/3 Channel Modulators toward Improved Balance of Lipophilicity and Aqueous Solubility
The voltage-gated potassium channel KV7.2/3 is gaining attention for its association with several medical indications. While recently reported, potent compounds aimed to fill the therapeutic gap left by market-withdrawn activators, key physicochemical parameters did not meet the requirements of potential drug candidates. Targeting the membrane-located channel requires subtly balancing lipophilicity, activity, and aqueous solubility. This publication describes the lead optimization of a highly active compound toward optimized physicochemical parameters. Out of 42 newly synthesized compounds, 30 showed activity on KV7.2/3 channels, and 15 had also an increased solubility compared the to hit compound. The integration of a three-dimensional bulky structure and the probable onset of chameleonic behavior, led to a 20-fold solubility increase (S = 21.7 vs 1.1 μM) and only slightly reduced potency (pEC50 = 7.42 vs 7.96) for the lead. Additionally, the target engagement of the compound was theoretically enhanced by a reduction of membrane retention.
期刊介绍:
The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents.
The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.